Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries In8Bio Inc (NQ: INAB ) 0.2850 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 964 Open 0.2850 Bid (Size) 0.2950 (40) Ask (Size) 0.3315 (15) Prev. Close 0.2850 Today's Range 0.2850 - 0.2850 52wk Range 0.2800 - 2.480 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News INAB Stock Earnings: IN8bio Misses EPS for Q2 2024 August 09, 2024 INAB stock results show that IN8bio missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 14, 2024 Via Benzinga Performance YTD -78.41% -78.41% 1 Month -44.87% -44.87% 3 Month -68.31% -68.31% 6 Month -75.85% -75.85% 1 Year -73.61% -73.61% More News Read More 12 Health Care Stocks Moving In Friday's Intraday Session June 14, 2024 Via Benzinga INAB Stock Earnings: IN8bio Misses EPS for Q1 2024 May 09, 2024 Via InvestorPlace INAB Stock Earnings: IN8bio Misses EPS for Q4 2023 March 14, 2024 Via InvestorPlace Gold Gains 1%; US Consumer Sentiment Falls In June June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 07, 2024 Via Benzinga IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights May 09, 2024 From IN8bio, Inc Via GlobeNewswire IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma April 30, 2024 From IN8bio, Inc Via GlobeNewswire IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting April 24, 2024 From IN8bio, Inc Via GlobeNewswire IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference April 16, 2024 From IN8bio, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session April 12, 2024 Via Benzinga Kill Leukemia Cells While Preserving Healthy Tissues: Nano-Cap Cancer Focused Firm IN8bio's Preclinical Candidate Shows Potential April 10, 2024 Via Benzinga Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket April 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 10, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 10, 2024 Via InvestorPlace IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024 April 09, 2024 From IN8bio, Inc Via GlobeNewswire IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights March 14, 2024 From IN8bio, Inc Via GlobeNewswire IN8bio to Present at Upcoming Investor Conferences February 26, 2024 From IN8bio, Inc. Via Business Wire IN8bio’s Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data January 23, 2024 Via News Direct IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data January 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 15, 2023 Via Benzinga Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 13, 2023 Via Benzinga Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket December 13, 2023 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
